Carilex Medical (ROCO:7726) Total Equity: NT$290.9 Mil (As of Dec. 2025)


ROCO:7726 Carilex Medical Inc ROCO:7726
34 GF Score
Price NT$31.85
! 5 Warning Signs
View Full Analysis

What is Carilex Medical Total Equity?

Carilex Medical ROCO:7726 34 Total Equity is NT$290.9 Mil as of Dec. 2025. GuruFocus rates ROCO:7726 with a GF Score™ of 34/100. The stock has 5 warning signs investors should review.

Carilex Medical's total equity for the quarter that ended in Dec. 2025 was NT$290.9 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Carilex Medical Total Equity Historical Data

* Premium members only.

The historical data trend for Carilex Medical's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carilex Medical Total Equity Chart

Carilex Medical Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial 203.56 237.18 351.48 330.04 290.93

Carilex Medical Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only 351.48 326.02 330.04 307.39 290.93
ROCO:7726
34GF Score
Carilex Medical Inc ROCO:7726
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Carilex Medical Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Carilex Medical's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=533.955-243.024
=290.9

Carilex Medical's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=533.955-243.024
=290.9

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of NT$290.9 Mil mean?
Carilex Medical (ROCO:7726) has a Total Equity of NT$290.9 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Carilex Medical and its competitors.
Is Carilex Medical's Total Equity too high?
Carilex Medical's current Total Equity is NT$290.9 Mil. Overall, Carilex Medical has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Carilex Medical's Total Equity compare to ABT and SYK?
Carilex Medical's Total Equity of NT$290.9 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Carilex Medical and its competitors. Carilex Medical's current Total Equity is NT$290.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carilex Medical stock overvalued right now?
Carilex Medical (ROCO:7726) has a current Total Equity of NT$290.9 Mil. The current Total Equity is NT$290.9 Mil. Carilex Medical's overall GF Score™ is 34/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Carilex Medical (ROCO:7726), the current Total Equity is NT$290.9 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Carilex Medical Business Description

Address No.77, Keji 1st Road, Guishan District, Taoyuan, TWN, 33383
Carilex Medical Inc is a company engaged in the wound care industry by developing leading-edge technology in the prevention and treatment of wounds. Their expertise is in research and development, manufacturing, and quality control and assurance allow us to provide unparalleled products in wound care management in the form of comprehensive product lines proven to prevent and manage pressure sores and wounds. They offer products in the form of Support Surfaces, Chair Cushion and Negative Pressure Wound Therapy.
34GF Score

Get the complete analysis for ROCO:7726

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$31.85
Price